Found: 8
Select item for more details and to access through your institution.
Evaluation of osimertinib efficacy according to body surface area and body mass index in patients with non‐small cell lung cancer harboring an EGFR mutation: A prospective observational study.
- Published in:
- Thoracic Cancer, 2019, v. 10, n. 4, p. 880, doi. 10.1111/1759-7714.13018
- By:
- Publication type:
- Article
Comparison of carboplatin plus etoposide with amrubicin monotherapy for extensive‐disease small cell lung cancer in the elderly and patients with poor performance status.
- Published in:
- Thoracic Cancer, 2018, v. 9, n. 8, p. 967, doi. 10.1111/1759-7714.12772
- By:
- Publication type:
- Article
Efficacy and risk of cytotoxic chemotherapy in extensive disease-small cell lung cancer patients with interstitial pneumonia.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Impact of EGFR genotype on the efficacy of osimertinib in EGFR tyrosine kinase inhibitor-resistant patients with non-small cell lung cancer: a prospective observational study.
- Published in:
- Cancer Management & Research, 2019, v. 11, p. 4883, doi. 10.2147/CMAR.S207170
- By:
- Publication type:
- Article
Real-world evaluation of carboplatin plus a weekly dose of nab-paclitaxel for patients with advanced non-small-cell lung cancer with interstitial lung disease.
- Published in:
- Cancer Management & Research, 2018, v. 10, p. 7013, doi. 10.2147/CMAR.S189556
- By:
- Publication type:
- Article
Smoking History as a Predictor of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Patients with Non-Small Cell Lung Cancer Harboring <bold>EGFR</bold> Mutations.
- Published in:
- Oncology, 2018, v. 95, n. 2, p. 109, doi. 10.1159/000488594
- By:
- Publication type:
- Article
Efficacy of Platinum-Based Chemotherapy for Relapsed Small-Cell Lung Cancer after Amrubicin Monotherapy in Elderly Patients and Patients with Poor Performance Status.
- Published in:
- Oncology, 2018, v. 94, n. 4, p. 207, doi. 10.1159/000486038
- By:
- Publication type:
- Article
Prognostic differences between oligometastatic and polymetastatic extensive disease-small cell lung cancer.
- Published in:
- PLoS ONE, 2019, v. 14, n. 5, p. 1, doi. 10.1371/journal.pone.0214599
- By:
- Publication type:
- Article